Wendy Stock

Wendy Stock

UNVERIFIED PROFILE

Are you Wendy Stock?   Register this Author

Register author
Wendy Stock

Wendy Stock

Publications by authors named "Wendy Stock"

Are you Wendy Stock?   Register this Author

100Publications

3267Reads

31Profile Views

Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL.

Blood 2019 Apr 22;133(16):1715-1719. Epub 2019 Feb 22.

Section of Hematology/Oncology, Department of Medicine, and University of Chicago Comprehensive Cancer Center, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-12-852376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634959PMC
April 2019

Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia.

Blood Adv 2019 01;3(1):96-104

Department of Medicine, University of Chicago Medicine, Chicago, IL; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018026211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325303PMC
January 2019

Should immunologic strategies be incorporated into frontline ALL therapy?

Best Pract Res Clin Haematol 2018 12 25;31(4):367-372. Epub 2018 Sep 25.

Pediatric Oncology Research Laboratory and Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Medicine, University of Chicago Medicine, Knapp Center for Biomedical Discovery, 900 E. 57th Street, 8th Floor Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.015DOI Listing
December 2018

Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician.

Clin Lymphoma Myeloma Leuk 2018 10 27;18(10):636-647. Epub 2018 Jun 27.

Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.06.017DOI Listing
October 2018

Refractory Hypokalemia from Syndrome of Apparent Mineralocorticoid Excess on Low-Dose Posaconazole.

Antimicrob Agents Chemother 2018 07 26;62(7). Epub 2018 Jun 26.

Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.02605-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021675PMC
July 2018

Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.

J Oncol Pharm Pract 2018 Jun 29;24(4):299-308. Epub 2017 Mar 29.

1 Department of Pharmacy, University of Chicago Medicine, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217701291DOI Listing
June 2018

"Dar"-ing to target CD38 in T-ALL.

Blood 2018 03;131(9):948-949

University of Chicago Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-01-826446DOI Listing
March 2018

Management of acute lymphoblastic leukemia in young adults.

Clin Adv Hematol Oncol 2018 Feb;16(2):138-146

Adolescent and Young Adult Oncology Program, University of Chicago Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
February 2018

Progress in adult ALL: incorporation of new agents to frontline treatment.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):28-36

University of Chicago Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.28DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142560PMC
December 2017

Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.

Leuk Lymphoma 2017 09 20;58(9):1-7. Epub 2017 Feb 20.

b Department of Medicine , Section of Hematology/Oncology, The University of Chicago Medicine , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1289524DOI Listing
September 2017

Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.

Cancer Epidemiol Biomarkers Prev 2017 03 16;26(3):312-320. Epub 2017 Feb 16.

Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-16-0722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546404PMC
March 2017

Counterpoint: Standard vs Investigational Agents as Upfront Treatment for High-Risk AML.

Oncology (Williston Park) 2017 Mar;31(3):190, 192

View Article

Download full-text PDF

Source
March 2017

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

J Clin Oncol 2017 Feb 21;35(4):394-401. Epub 2016 Nov 21.

Kathryn G. Roberts, Zhaohui Gu, Debbie Payne-Turner, Kelly McCastlain, Deqing Pei, Ilaria Iacobucci, Marcus Valentine, Stanley B. Pounds, Lei Shi, Yongjin Li, Jinghui Zhang, Cheng Cheng, and Charles G. Mullighan, St Jude Children's Research Hospital, Memphis, TN; Richard C. Harvey, I-Ming Chen, and Cheryl L. Willman, University of New Mexico Cancer Center, Albuquerque, NM; Alessandro Rambaldi, Manuela Tosi, and Orietta Spinelli, Ospedale Papa Giovanni XXIII, Bergamo, Italy; Jerald P. Radich, Fred Hutchinson Cancer Research Center, Seattle, WA; Mark D. Minden, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Jacob M. Rowe, Shaare Zedek Medical Center, Jerusalem, Israel; Selina Luger, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Mark R. Litzow, Mayo Clinic, Rochester, MN; Martin S. Tallman, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York; Peter H. Wiernik, Cancer Research Foundation of New York; Elisabeth Paietta, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Ravi Bhatia, The University of Alabama at Birmingham, Birmingham, AL; Ibrahim Aldoss and Guido Marcucci, City of Hope, Duarte, CA; Jessica Kohlschmidt, Krzysztof Mrózek, and Clara D. Bloomfield, Comprehensive Cancer Center, The Ohio State University, Columbus, OH; Wendy Stock, University of Chicago Medical Center, Chicago, IL; and Stephen Kornblau, Hagop M. Kantarjian, and Marina Konopleva, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455698PMC
February 2017

The Persistence of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?

Biol Blood Marrow Transplant 2016 11 12;22(11):1913-1914. Epub 2016 Sep 12.

Department of Medicine, University of Chicago Medical Center, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.09.008DOI Listing
November 2016

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

N Engl J Med 2016 11;375(21):2023-2036

the Department of Internal Medicine, Division of Oncology (J.S.W., L.D.W., G.L.U., A.G., M.H.T., I.P., R.R., T.A.F., K.E.S.-G., R.V., S.T.O., C.N.A., A.F.C., M.A.S., M.A.J., S.E.H., K.L., M.R.J., M.J.W., P.W., D.C.L., J.F.D., T.J.L.), and the Division of Biostatistics (J.D.B.), and the Department of Pathology and Immunology (E.J.D., B.T., Y.-S.L.), Washington University School of Medicine, and McDonnell Genome Institute, Washington University in St. Louis (A.A.P., C.A.M., C.C.F., M.O., R.S.F., R.K.W., L.D.W., T.J.L.) - both in St. Louis; the Departments of Internal Medicine (A.H., N.K., M.J.S., W.S.) and Pharmacy (R.W.K.), University of Chicago, Chicago; and the Department of Internal Medicine (T.A.G.), Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1605949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217532PMC
November 2016

Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia?

Leuk Lymphoma 2015 19;56(11):3005-7. Epub 2015 Jun 19.

a Department of Medicine , Section of Hematology/Oncology, The University of Chicago Medical Center , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1048444DOI Listing
September 2016

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

N Engl J Med 2016 Aug 12;375(8):740-53. Epub 2016 Jun 12.

From the University of Texas MD Anderson Cancer Center, Houston (H.M.K.); the Dana-Farber Cancer Institute, Boston (D.J.D.), and Pfizer, Cambridge (E.V.) - both in Massachusetts; Universitätsklinikum Münster, Münster (M.S.), and Goethe University, Frankfurt (N.G.) - both in Germany; Institute Seràgnoli, DIMES (Department of Experimental, Diagnostic and Specialty Medicine), University of Bologna, Bologna, Italy (G.M.); Stanford Cancer Institute, Stanford (M.L.), and the University of California, Irvine Medical Center, Orange (S.O.) - both in California; the University of Chicago, Chicago (W.S.); Pfizer, Pearl River, NY (K.W.); Pfizer, Groton, CT (T.W., M.L.P., B.S.); and Cleveland Clinic, Cleveland (A.S.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1509277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594743PMC
August 2016

Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemia.

Leuk Lymphoma 2016 07;57(7):1527-33

b Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1160085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968046PMC
July 2016

Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship.

Cancer 2016 Mar 7;122(6):954-61. Epub 2016 Jan 7.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29868DOI Listing
March 2016

Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.

Leuk Res 2015 Dec 1;39(12):1437-42. Epub 2015 Oct 1.

Division of Oncology, Washington University School of Medicine, St. Louis, MO, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.09.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661095PMC
December 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Novel drug targets in acute leukemia.

Authors:
Wendy Stock

Clin Adv Hematol Oncol 2015 Aug;13(8):493-5

Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
August 2015

How I treat acute lymphoblastic leukemia in older adolescents and young adults.

Blood 2015 Jun 24;125(24):3702-10. Epub 2015 Mar 24.

University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-11-551481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463735PMC
June 2015

Minimal residual disease in acute myeloid leukemia--current status and future perspectives.

Curr Hematol Malig Rep 2015 Jun;10(2):132-44

Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-015-0260-7DOI Listing
June 2015

RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.

Leuk Lymphoma 2015 Apr 26;56(4):1145-7. Epub 2014 Aug 26.

Department of Medicine, The University of Chicago , Chicago, IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.951851DOI Listing
April 2015

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

N Engl J Med 2014 Sep;371(11):1005-15

From the Departments of Pathology (K.G.R., D.P.-T., Y.-L.Y., K. McCastlain, G.S., J.M., S.-C.C., J.C., N.S.-M., I.I., J.W., J.R.D., C.G.M.), Computational Biology and Bioinformatics (Y.L., J.B., M.R., E.H., P.G., P.N., G.W., X.C., J.Z.), Biostatistics (D.P., C.C.), Pharmaceutical Sciences (S.W.P., M.V.R., W.E.E.), and Oncology (C.-H.P., S.J.), the Pediatric Cancer Genome Project (Y.L., L.D., C.L., M.R., J.E., J.C., K.B., R.S.F., E.H., P.G., P.N., G.W., X.C., D.Y., B.V., H.M., M.V.R., W.E.E., E.M., R.K.W., J.R.D., J.Z., C.G.M.), and Cytogenetics Shared Resource (M.V.), St. Jude Children's Research Hospital, Memphis, TN; the University of New Mexico Cancer Center and School of Medicine, Albuquerque (R.C.H., I-M.C., C.L.W.); the Genome Institute at Washington University (L.D., C.L., R.S.F., E.M., R.K.W.), the Department of Genetics, Washington University School of Medicine (L.D., C.L., R.S.F., E.M., R.K.W.), and Siteman Cancer Center, Washington University (E.M., R.K.W.) - all in St. Louis; Epidemiology and Health Policy Research, College of Medicine, University of Florida, Gainesville (M.D.); the Research Institute at Nationwide Children's Hospital (S.R., A.S., J.M.G.-F.), the Department of Pathology, College of Medicine, Ohio State University (N.A.H.), and Ohio State University Comprehensive Cancer Center (G.M., C.D.B., K. Mrózek, J.K.) - all in Columbus, OH; the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (N.J.W.), Scott and White Hospitals and Clinics and Texas A&M Health Science Center, Temple (G.G.), the University of Texas Health Science Center San Antonio, San Antonio (M.F.-J.), and the Departments of Leukemia and Stem Cell Transplantation, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (S.M.K., M.K.) - all in Texas; Maine Children's Cancer Program, Scarborough (E.C.L.); New York University Cancer Institute, New York (W.L.C.), and the Department of Medicine (Oncology), Albert Einstein

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1403088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191900PMC
September 2014

MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.

Cancer Cell 2014 May 1;25(5):652-65. Epub 2014 May 1.

Cancer Biology and Genetics Program, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2014.03.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206212PMC
May 2014

A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469.

Pharmacogenet Genomics 2014 Feb;24(2):129-32

aDepartment of Medicine, The University of Chicago, Chicago, Illinois bDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901533PMC
February 2014

Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.

Clin Cancer Res 2014 Jan 31;20(2):490-8. Epub 2013 Oct 31.

Authors' Affiliations: The University of Chicago; Decatur Memorial Hospital, Decatur; Illinois Cancer Care, Peoria; Loyola University Medical Center, Maywood, Illinois; University of California, San Francisco, San Francisco; City of Hope, Duarte, California; University of Michigan Medical Center, Ann Arbor, Michigan; Medical College of Wisconsin, Milwaukee, Wisconsin; and National Cancer Institute, Rockville, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310865PMC
January 2014

Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.

Biol Blood Marrow Transplant 2013 May 8;19(5):682-91. Epub 2012 Nov 8.

Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.11.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618995PMC
May 2013

Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies.

Curr Opin Hematol 2013 Mar;20(2):115-22

Section of Hematology/Oncology, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e32835dd84aDOI Listing
March 2013

Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia.

Leuk Lymphoma 2012 Aug 1;53(8):1543-51. Epub 2012 Mar 1.

Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.660631DOI Listing
August 2012

Influence of related donor age on outcomes after peripheral blood stem cell transplantation.

Cytotherapy 2012 Jul 2;14(6):707-15. Epub 2012 May 2.

Biological Sciences Division, Department of Pathology, Section of Blood Bank and Transfusion Medicine, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/14653249.2012.681041DOI Listing
July 2012